KalVista Pharmaceuticals, Inc. (KALV)
NASDAQ: KALV · Real-Time Price · USD
26.79
0.00 (0.00%)
May 22, 2026, 4:00 PM EDT - Market closed
KalVista Pharmaceuticals Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Needham | Needham | Hold Maintains n/a | Hold | Maintains | n/a | n/a | May 15, 2026 |
| Stifel Nicolaus | Stifel Nicolaus | Hold Downgrades $42 → $27 | Hold | Downgrades | $42 → $27 | +0.78% | May 7, 2026 |
| H.C. Wainwright | H.C. Wainwright | Hold Downgrades $37 → $27 | Hold | Downgrades | $37 → $27 | +0.78% | May 1, 2026 |
| JonesTrading | JonesTrading | Hold Downgrades $39 → $27 | Hold | Downgrades | $39 → $27 | +0.78% | Apr 29, 2026 |
| Leerink Partners | Leerink Partners | Hold Downgrades $27 | Hold | Downgrades | $27 | +0.78% | Apr 29, 2026 |
| Citizens JMP | Citizens JMP | Hold Downgrades n/a | Hold | Downgrades | n/a | n/a | Apr 29, 2026 |
| Bank of America Securities | Bank of America Securities | Buy Reiterates $32 | Buy | Reiterates | $32 | +19.45% | Apr 16, 2026 |
| TD Cowen | TD Cowen | Buy Maintains $35 | Buy | Maintains | $35 | +30.65% | Mar 25, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.